Shane Bowen
Directeur Technique/Scientifique/R&D chez STANDARD BIOTOOLS INC.
Postes actifs de Shane Bowen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| STANDARD BIOTOOLS INC. | Directeur Technique/Scientifique/R&D | 05/01/2024 | - |
Palamedrix, Inc.
 Palamedrix, Inc. Miscellaneous Commercial ServicesCommercial Services Part of SomaLogic, Inc., Palamedrix, Inc. engages in leveraging DNA nanotechnology for revolutionary advancements in life science and medicine. The company is based in La Jolla, CA. The company was founded by Shane Bowen, Paul W. K. Rothemund, Ashwin Gopinath. Shane Bowen has been the CEO since incorporation. Palamedrix was acquired by SomaLogic, Inc. on September 30, 2022 for $52.50 million. | Directeur Général | - | - |
| Fondateur | - | - | |
| President | - | - |
Historique de carrière de Shane Bowen
Statistiques
Internationale
| Etats-Unis | 3 |
Opérationnelle
| Chief Executive Officer | 1 |
| Founder | 1 |
| President | 1 |
Sectorielle
| Commercial Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| STANDARD BIOTOOLS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Palamedrix, Inc.
Palamedrix, Inc. Miscellaneous Commercial ServicesCommercial Services Part of SomaLogic, Inc., Palamedrix, Inc. engages in leveraging DNA nanotechnology for revolutionary advancements in life science and medicine. The company is based in La Jolla, CA. The company was founded by Shane Bowen, Paul W. K. Rothemund, Ashwin Gopinath. Shane Bowen has been the CEO since incorporation. Palamedrix was acquired by SomaLogic, Inc. on September 30, 2022 for $52.50 million. | Commercial Services |
- Bourse
- Insiders
- Shane Bowen
- Expérience
